bexarotene gel
bexarotene gel information and resources from the National Cancer Institute
Targretin
For the topical treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy.
Ligand Pharmaceuticals Jun 28 2000
bexarotene gel -->
Home
|
About
|
Search topics
|
Cancers
|
Treatment
|
Medications
Onconews provides free news and resources on cancer-related topics.
Copyright onconews.org 2005-2006.
All Rights Reserved.
Web
onconews.org